double-skinned crabsVietnamese crab exporter
Advertisement
Advertisement
TOPIC

Medicine

Medicine
The latest news, analysis and opinion on Medicine. In-depth analysis, industry insights and expert opinion.
AstraZeneca has moved to advance Chinese biotech firm Akeso’s flagship cancer drug. Photo: Reuters
Biomedicine: Companies

AstraZeneca, Merck, Novo deals inject fresh global momentum into Chinese biotech

Deals involving novel cancer therapies and weight-loss drugs reinforce the growing global appeal of Chinese biotech innovation.

Wellness

What’s the future of heart health? Cardiologists on advances, life-saving habits

videocam
Wellness

The hidden risks of using Chinese medicine with Western prescriptions

Hong Kong healthcare and hospitals

Editorial | Hong Kong’s fight against cancer must begin with early screening

The city’s achievements in cutting the rate of cancer-related deaths is impressive but more can be done to ensure timely diagnosis.

Advances in treating lung cancer – the most common and deadliest type in the city – such as targeted therapy and immunotherapy had improved global survival rates. Photo: Getty Images
Biomedicine: Industry Trends

How Chinese biotech is graduating from licensing deals to broader partnerships

InnoCare’s pact with Eli Lilly, potentially worth up to US$3.35 billion, highlights a shift towards bigger partnerships, analysts say.

Cancer

How FDA backing could advance multi-cancer blood tests despite Hong Kong doubts

Doctors say more data is needed despite growing interest in detecting multiple cancers from a single blood sample.

Advertisement
Advertisement
Advertisement
Hong Kong healthcare and hospitals

Hong Kong reports more than 40% drop in cancer-related death rate over 30 years

Health minister Lo Chung-mau outlines Hong Kong’s ‘remarkable’ progress at the World Cancer Congress, being held in the city for the first time.

Hong Kong has reduced its age-standardised cancer mortality rate by more than 40 per cent in three decades, according to Health Secretary Lo Chung-mau. Photo: Sam Tsang
China technology

Are clinical trials about to become a new front in the US-China biotech race?

China’s ability to conduct clinical trials quickly and cheaply has given it an edge in the biotech sector – and the US is growing concerned.

UAVs (unmanned aerial vehicles)

Eyeing Ukraine, China’s military doctors voice progress on drone-caused injuries

Head, face and neck injuries are becoming a big problem in armed conflicts dominated by uncrewed aerial vehicles.

videocam
Hong Kong stock market

‘High tide’ of China biotech deals seen as US curb fears fade: analysts

Stocks jump on reports Washington will allow most licensing deals under ‘substantially softer stance’ than had been feared, analysts say.

videocam
Employees work at a Fosun Pharmaceuticals facility in Shanghai. Photo: Handout
Wellness

Why dementia is preventable – and the new tools that can reduce your risk

On World Alzheimer’s Day, a look at advances in dementia diagnosis and treatment, and why much of the risk may be within our own control.

A group of elderly people gather to swim. Research increasingly shows that dementia is anything but inevitable and that we have more control over the risks than once believed. Photo: Shutterstock
Biomedicine: Industry Trends

Can targeted sound waves transform treatment for pancreatic and brain cancers?

A leading advocate says global trials in pancreatic and brain cancers may yield results within 3 years, with Alzheimer’s another application.

Thailand

Thailand makes weight-loss pens prescription-only to counter abuse

The country’s consumer watchdog aims to help patients receive ‘higher quality, safer, and more appropriate for their treatment’.

Biomedicine: Companies

GSK’s US$750 million cancer drug deal highlights China’s rise as biotech player

The acquisition is the latest in a string of major licensing deals involving Chinese biotechnology firms.

4
GSK has agreed a deal worth up to US$750 million to license a T-cell engager from a Chinese biotechnology firm. Photo: Reuters
United States

Ozempic-maker Novo Nordisk slims down to ‘Novo’

It will keep the full Novo Nordisk as its legal corporate name, using Novo and an updated version of its bull logo for its packaging.

videocam
The headquarters of pharmaceutical giant Novo Nordisk in Bagsvaerd in Denmark. The company is battling fierce competition in the anti-obesity sector, where its hugely successful Ozempic and Wegovy treatments have spurred rivals to catch up. Photo: EPA
Greater Bay Area

Data from Greater Bay Area residents to help improve healthcare policy: GSK

Executive says pharmaceutical company is investing in shared data infrastructure.

Hong Kong healthcare and hospitals

Unvaccinated children, elderly face much higher risk of major flu complications

Hong Kong director of health cites data showing unvaccinated children and elderly are four to five times more vulnerable than vaccinated individuals.

Advertisement
Advertisement
Advertisement
China’s private sector

China needs monkeys: lab animal shortage could hinder biotech growth

As fundraising and out-licensing deals in China grow, so does demand for monkeys and other primates for testing.

The expansion of China’s biotechnology industry is driving up demand for primates. Photo: Shutterstock
Wellness

I survived breast cancer. 12 years later, my body sent another warning

This Gynaecologic Cancer Awareness Month, US-based author and filmmaker Amy Wu shares her experience of dealing with cancer – twice.

Science

US, China trials suggest a single nanodrug shot might stop bad cholesterol forever

Separate trials using CRISPR and base editing to silence lipid genes show drastic drops in LDL-C without daily medication.

videocam
Hong Kong healthcare and hospitals

‘There are trade-offs’: how Hong Kong patients can use telemedicine wisely

Hospital Authority telehealth cases jump 33 per cent as private clinics tailor services for people with busy schedules.

Illustration: Henry Wong
Crime in Hong Kong

IVF clinic’s embryo specimen mix-up linked to ‘intentional unlawful conduct’

Watchdog says it has ordered Heal Fertility to comply with law and code of practice to prevent recurrence of similar incidents.

Heal Fertility earlier apologised to affected clients and submitted an internal investigation report to health authorities. Photo: Jelly Tse
China technology

China approves string of ‘telepathy’ devices amid push to leapfrog Elon Musk

Chinese regulators have approved a group of brain-technology products this year, as local start-ups push to surpass Musk’s Neuralink.

Hong Kong healthcare and hospitals

Can Hongkongers trust smartwatches, or are they being misled?

Medical practitioners and fitness experts say wearable tech could support personalised, proactive healthcare as adoption hits 63 per cent among Hongkongers.

Wellness

1 in 20 Hongkongers has hepatitis B, many unaware. What are the risks?

Hepatitis B is a viral liver infection that can cause cirrhosis and liver cancer. A vaccine exists, but many don’t know they are infected.

Hepatitis B is endemic in Hong Kong, affecting 5 per cent of the population. However, 40 per cent of those who have it are unaware they are infected. Illustration: Mario Cameira
Hong Kong stock market

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

The biliary tract cancer trial is the latest breakthrough for Akeso’s ivonescimab, which has also shown promise in treating some lung cancers.

China’s biopharmaceutical firms are increasingly looking to compete directly on the global market. Photo: Shutterstock
Wuxi Biologics

WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwinds

Higher gross margins, surging projects and continued demand from North American markets help power the drug developer’s strong first-half performance.

Health in China

Overseas licensing has helped fuel China’s biotech profits. Will it last?

Out-licensing deals have overtaken IPOs as the primary lifeline for cash-starved Chinese drug makers, analysts say.

videocam
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement